Sun extends tender offer and receives FDA approval for four products
This article was originally published in Scrip
Executive Summary
Alkaloida Chemical Company Exclusive Group, a subsidiary ofSun Pharmaceutical Industries, has extended the closing date of its tender offer for the purchase of all outstanding ordinary shares of Taro Pharmaceutical Industriesto January 30th from the previously scheduled date of January 9th.